Maja Tomičić

3.7k total citations
83 papers, 3.0k citations indexed

About

Maja Tomičić is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Maja Tomičić has authored 83 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 22 papers in Oncology and 14 papers in Hematology. Recurrent topics in Maja Tomičić's work include DNA Repair Mechanisms (27 papers), Cancer-related Molecular Pathways (15 papers) and Cell death mechanisms and regulation (10 papers). Maja Tomičić is often cited by papers focused on DNA Repair Mechanisms (27 papers), Cancer-related Molecular Pathways (15 papers) and Cell death mechanisms and regulation (10 papers). Maja Tomičić collaborates with scholars based in Germany, Croatia and United States. Maja Tomičić's co-authors include Bernd Kaina, Markus Christmann, Wynand P. Roos, Beate Köberle, Dorthe Aasland, R Thust, Thomas Efferth, Mirza Bojić, Rolf Rauh and Sabine Grösch and has published in prestigious journals such as Nucleic Acids Research, Cancer Research and Oncogene.

In The Last Decade

Maja Tomičić

80 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maja Tomičić Germany 30 1.9k 783 614 268 235 83 3.0k
Yue Huang China 34 2.1k 1.1× 744 1.0× 330 0.5× 202 0.8× 267 1.1× 101 3.6k
Vassilis Zoumpourlis Greece 27 1.4k 0.8× 549 0.7× 428 0.7× 236 0.9× 174 0.7× 76 2.4k
In‐Chul Park South Korea 32 1.8k 1.0× 543 0.7× 589 1.0× 126 0.5× 147 0.6× 116 2.8k
William L. Blalock Italy 30 2.9k 1.5× 931 1.2× 699 1.1× 200 0.7× 197 0.8× 73 4.3k
Emilia Wiecheć Sweden 29 2.1k 1.1× 1.1k 1.4× 815 1.3× 180 0.7× 193 0.8× 46 3.7k
Hyog Young Kwon South Korea 23 2.5k 1.3× 1.1k 1.4× 605 1.0× 381 1.4× 156 0.7× 43 3.7k
Emanuela Grassilli Italy 29 1.9k 1.0× 797 1.0× 418 0.7× 180 0.7× 157 0.7× 58 2.9k
Adriana Borriello Italy 29 1.3k 0.7× 504 0.6× 310 0.5× 143 0.5× 200 0.9× 73 2.4k
Megan Cully United Kingdom 17 2.2k 1.2× 464 0.6× 760 1.2× 141 0.5× 133 0.6× 128 3.4k
Subbareddy Maddika India 28 2.1k 1.1× 596 0.8× 367 0.6× 92 0.3× 296 1.3× 48 2.9k

Countries citing papers authored by Maja Tomičić

Since Specialization
Citations

This map shows the geographic impact of Maja Tomičić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maja Tomičić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maja Tomičić more than expected).

Fields of papers citing papers by Maja Tomičić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maja Tomičić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maja Tomičić. The network helps show where Maja Tomičić may publish in the future.

Co-authorship network of co-authors of Maja Tomičić

This figure shows the co-authorship network connecting the top 25 collaborators of Maja Tomičić. A scholar is included among the top collaborators of Maja Tomičić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maja Tomičić. Maja Tomičić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rinke, Jenny, et al.. (2025). Therapy-induced senescence of glioblastoma cells is determined by the p21CIP1-CDK1/2 axis and does not require activation of DREAM. Cell Death and Disease. 16(1). 357–357. 3 indexed citations
4.
Chen, Jia‐Xuan, Georg Nagel, Petra Beli, et al.. (2024). The p21CIP1-CDK4-DREAM axis is a master regulator of genotoxic stress-induced cellular senescence. Nucleic Acids Research. 52(12). 6945–6963. 11 indexed citations
5.
Christmann, Markus, et al.. (2022). Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?. Cancers. 14(10). 2416–2416. 24 indexed citations
6.
Tomičić, Maja, et al.. (2021). Oxaliplatin-Induced Senescence in Colorectal Cancer Cells Depends on p14ARF-Mediated Sustained p53 Activation. Cancers. 13(9). 2019–2019. 19 indexed citations
7.
Kaina, Bernd, et al.. (2021). Targeting c-IAP1, c-IAP2, and Bcl-2 Eliminates Senescent Glioblastoma Cells Following Temozolomide Treatment. Cancers. 13(14). 3585–3585. 25 indexed citations
8.
Mayer, Laura, et al.. (2020). Benzo[a]pyrene represses DNA repair through altered E2F1/E2F4 function marking an early event in DNA damage-induced cellular senescence. Nucleic Acids Research. 48(21). 12085–12101. 30 indexed citations
9.
Bojić, Mirza, et al.. (2019). Antithrombotic activity of flavonoids and polyphenols rich plant species. Acta Pharmaceutica. 69(4). 483–495. 51 indexed citations
10.
Aasland, Dorthe, Laura Hauck, Simon Schneider, et al.. (2018). Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR–CHK1, p21, and NF-κB. Cancer Research. 79(1). 99–113. 147 indexed citations
11.
Aasland, Dorthe, et al.. (2017). Repair gene O6‐methylguanine‐DNA methyltransferase is controlled by SP1 and up‐regulated by glucocorticoids, but not by temozolomide and radiation. Journal of Neurochemistry. 144(2). 139–151. 40 indexed citations
12.
Tomičić, Maja, et al.. (2015). [Indications and contraindications for platelet transfusions in patients with thrombocytopenia].. PubMed. 136(3-4). 90–3. 1 indexed citations
13.
Tomičić, Maja, Dorthe Aasland, Steffen C. Naumann, et al.. (2014). Translesion Polymerase η Is Upregulated by Cancer Therapeutics and Confers Anticancer Drug Resistance. Cancer Research. 74(19). 5585–5596. 52 indexed citations
14.
Tomičić, Maja, et al.. (2014). INDIKACIJE I KONTRAINDIKACIJE ZA PRIMJENU TROMBOCITNIH TRANSFUZIJA U BOLESNIKA S TROMBOCITOPENIJOM. University of Zagreb University Computing Centre (SRCE). 136. 0–0. 1 indexed citations
15.
Köberle, Beate, et al.. (2010). Cisplatin resistance: Preclinical findings and clinical implications. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1806(2). 172–182. 305 indexed citations
16.
Christmann, Markus, et al.. (2010). Three prime exonuclease I (TREX1) is Fos/AP-1 regulated by genotoxic stress and protects against ultraviolet light and benzo(a)pyrene-induced DNA damage. Nucleic Acids Research. 38(19). 6418–6432. 54 indexed citations
17.
Tomičić, Maja, et al.. (2004). 5, 10-Methylenetetrahydrofolate reductase (MTHFR) 677 C --> T genetic polymorphism in 228 Croatian volunteers.. PubMed. 28(2). 647–54. 10 indexed citations
18.
Kaina, Bernd, et al.. (2001). BER, MGMT, and MMR in defense against alkylation-induced genotoxicity and apoptosis. Progress in nucleic acid research and molecular biology. 68. 41–54. 81 indexed citations
20.
Olea, Elena, et al.. (1996). [Nationally produced 153SmEDTMP in the palliative treatment of metastatic bone cancer pain].. PubMed. 124(7). 805–12. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026